Plain-English translation of NCT06201455 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a combined surgical approach for people who have both glaucoma (high eye pressure that damages vision) and cataracts (clouding of the lens). Half of the participants will receive cataract surgery paired with a newer, minimally invasive glaucoma procedure called goniotomy. The other half will receive cataract surgery alone and continue their regular eye pressure medications. The goal is to see whether adding the glaucoma procedure can help reduce—or even eliminate—the need for daily medicated eye drops.
Many people with glaucoma rely on multiple eye drops every day, which can be expensive, cause side effects, and be hard to remember to use consistently. This trial exists to find out whether a less invasive surgical option can help patients control their eye pressure without so much medication.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be randomly assigned to receive either combined cataract and glaucoma surgery, or cataract surgery followed by continued eye drop treatment. You will have the surgery at a participating hospital, and then return for follow-up visits to monitor your eye pressure, vision, and how well you're doing. The study will track whether you need fewer medications over time and how your quality of life has changed.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China